Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2024-08-12 00:00:00 ET · period of report 2024-08-08 · accession 0000875320-24-000204 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-12 | 2024-08-08 | VRTX | Bhatia Sangeeta N. | Dir | S - Sale+OE | $466.29 | -1,292 | 4,435 | -23% | -$602.4K |
| D | 2024-08-12 | 2024-08-08 | VRTX | Bhatia Sangeeta N. | Dir | M - OptEx | $152.74 | +1,292 | 5,727 | +29% | +$197.3K |
| D | 2024-08-12 | 2024-08-08 | VRTX | Bhatia Sangeeta N. | Dir | M - OptEx | $0.00 | -1,292 | 646 | -67% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-08 | S | D | 1,292 | $466.29 | 4,435 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-08 | M | A | 1,292 | $152.74 | 5,727 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-08-08 | M | D | 1,292 | $0.00 | 646 | D | $152.74 · — to 2028-05-31 | 1,292 Common Stock | (F2) Fully vested. |